dc.contributor.author | Apikoglu-Rabus, Sule | |
dc.contributor.author | Kiran, Bayram | |
dc.contributor.author | Karagoz, Turan | |
dc.contributor.author | Izzettin, Fikret Vehbi | |
dc.contributor.author | Clark, Philip Martin | |
dc.date.accessioned | 2021-03-03T17:30:37Z | |
dc.date.available | 2021-03-03T17:30:37Z | |
dc.identifier.citation | Clark P. M. , Apikoglu-Rabus S., Kiran B., Karagoz T., Izzettin F. V. , "A Prospective Assessment of Therapeutic Efficacy and Immune Effects of Levofloxacin and Ofloxacin in Multiple-Drug Resistant Tuberculosis", DRUG-RESISTANT TUBERCULOSIS: CAUSES, DIAGNOSIS AND TREATMENTS, ss.237-249, 2010 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_4a196ae9-3e7c-4416-8696-f662faa20413 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/53243 | |
dc.description.abstract | Background: Multi-drug resistant tuberculosis impairing the effectiveness of standard treatments may contribute to increased mortality. High failure and relapse rates are recorded when standard regimens are used for multi-drug resistant tuberculosis. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Mikrobiyoloji ve Klinik Mikrobiyoloji | |
dc.subject | Viroloji | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Mikrobiyoloji | |
dc.subject | VİROLOJİ | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | İmmünoloji | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.title | A Prospective Assessment of Therapeutic Efficacy and Immune Effects of Levofloxacin and Ofloxacin in Multiple-Drug Resistant Tuberculosis | |
dc.type | Makale | |
dc.relation.journal | DRUG-RESISTANT TUBERCULOSIS: CAUSES, DIAGNOSIS AND TREATMENTS | |
dc.contributor.department | Yeditepe Üniversitesi , , | |
dc.identifier.startpage | 237 | |
dc.identifier.endpage | 249 | |
dc.contributor.firstauthorID | 136792 | |